Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Other financing activities (2016 - 2025)

Historic Other financing activities for AtriCure (ATRC) over the last 16 years, with Q3 2025 value amounting to $6.2 million.

  • AtriCure's Other financing activities rose 922835.82% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year increase of 48465.86%. This contributed to the annual value of $1.1 million for FY2024, which is 168166.67% up from last year.
  • As of Q3 2025, AtriCure's Other financing activities stood at $6.2 million, which was up 922835.82% from $67000.0 recorded in Q3 2024.
  • In the past 5 years, AtriCure's Other financing activities ranged from a high of $10.2 million in Q2 2021 and a low of -$6.3 million during Q3 2021
  • Its 4-year average for Other financing activities is $950000.0, with a median of $142000.0 in 2024.
  • Over the last 5 years, AtriCure's Other financing activities had its largest YoY gain of 11700000.0% in 2021, and its largest YoY loss of 21445.3% in 2021.
  • Quarter analysis of 4 years shows AtriCure's Other financing activities stood at $1.2 million in 2021, then tumbled by 94.88% to $60000.0 in 2023, then increased by 11.67% to $67000.0 in 2024, then surged by 9228.36% to $6.2 million in 2025.
  • Its Other financing activities stands at $6.2 million for Q3 2025, versus $67000.0 for Q3 2024 and $142000.0 for Q2 2024.